ClinicalTrials.govpublic full text
DAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral)
hepatitis c, acute/early chronic, recently acquired, directly acting antiviral therapy, sofosbuvir, ribavirin, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 836732
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.